Search this site:
SORIN GROUP ANNOUNCES FDA APPROVAL AND U.S. LAUNCH OF SMARTVIEW (tm) REMOTE MONITORING SOLUTION FOR PATIENTS WITH IMPLANTED CARDIAC DEFIBRILLATORS
Denver, May 10
2013 – Sorin Group, (Reuters Code: SORN.MI), a global medical ...
SORIN S.P.A. STOCKHOLDERS’ MEETING APPROVES 2012 FINANCIAL RESULTS AND APPOINTS BOARD OF STATUTORY AUDITORS
Milan, April 30, 2013 – At a meeting held today and chaired by Rosario Bifulco, the Sorin ...
SORIN GROUP RECEIVES CONDITIONAL FDA APPROVAL TO CONDUCT IDE CLINICAL TRIAL FOR PERCEVAL™ S SUTURELESS AORTIC VALVE IN THE UNITED STATES
Primary objective of the prospective, non randomized trial is to demonstrate the safety and ...
Cardiac Rhythm Management
Working at Sorin
Check for jobs